Dr. Robert Hardi, M.D.

Clinical Trials

• Study of the Effect of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Ulcerative Colitis Who Achieved Clinical Response in Induction Studies
• A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
• A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Ulcerative Colitis
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Media Releases

Get to know Gastroenterologist Dr. Robert Hardi, who serves patients in Bethesda, Maryland.

A seasoned gastroenterologist, Dr. Hardi has been splitting his time among clinical practice, consulting, and medical research for more than 40 years. His particular clinical interests are inflammatory bowel disease (he served on the National Board of the Crohn’s and Colitis Foundation of America) and colorectal cancer screening.

In addition to working with patients at his private practice in Bethesda, Maryland, he serves as a Medical Director of Altimmune, and Chief Clinical Scientist for MediPredict. He is also the Principal at Chevy Chase Gastroenterology, and a gastroenterology consultant for Physician Associates.

Back in the early days of his academic career, Dr. Hardi graduated summa cum laude from the Semmelweis University Medical School in Budapest in 1972. He completed his post graduate training in Biochemistry and Genetics and was an Assistant Professor of Genetics at the Eotvos University of Sciences in Budapest.

Subsequently, he served as a postdoctoral Fellow at Roswell Park Memorial Institute, before starting his clinical training in internal medicine, which he completed in Budapest and at the University Medical School in Hanover, Germany. He completed his clinical fellowship training in hematology and medical oncology at the University of New Mexico, and his fellowship in gastroenterology at Cornell University Medical School/The New York Hospital.

Passionate about his profession, the doctor is board-certified in gastroenterology and  by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Maintaining fellowship status, Dr. Hardi is a Fellow of the American Gastroenterological Association (AGAF), and Fellow of the Academy of Physicians in Clinical Research (FAPCR).

In 1996, he founded and was the Medical Director and Principal Investigator of Chevy Chase Clinical Research, which has participated in more than 350 studies in all areas of gastroenterology. He has also served on the Board and as President of the Academy of Physicians in Clinical Research, and has held various positions at Capitol Research, Metropolitan Gastroenterology Group, and Capital Digestive Care.

De. Hardi is also Clinical Associate Professor of Medicine at The George Washington University Medical School.

Gastroenterology is the branch of medicine focused on the digestive system and its disorders. A gastroenterologist is a physician who has extensive training in the diagnosis and treatment of disorders related to the esophagus, stomach, small intestines, colon, liver, pancreas, and biliary system.

An authority in his field, Dr. Hardi has been many times the recipient of the Best Doctor Award by Washingtonian Magazine, and Patients' Choice Award.

Speaking several languages, he is fluent in English, Hungarian, and German.

Recommended Articles

• New Crohn's and Colitis Treatment May Combine Antifungals and Probiotics

  A recent review, published in the Digestive and Liver Disease journal, proposes that new types of IBD treatment can come from combining antifungals with probiotics. Probiotics are live microorganisms that are believed to offer health-related benefits when consumed and bacteria can contain probiotic...

• Teen Celiac Disease Patient Starts a Kosher Gluten-Free Food Bank

  Celiac disease is a type of autoimmune disease that interferes with the absorption of nutrients while also damaging the small intestines. People with this disease cannot tolerate gluten, which is a nutrient not only found in a lot of the food found in the supermarket, but also commonly used in...

• Dealing with Ulcerative Colitis Flare-Ups

  Ulcerative colitis can really send patients on a life-changing roller coaster ride. And not the good kind of roller coaster.UC can be unpredictable and cause people to experience a range of inconsistent symptoms such as diarrhea, constipation, abdominal pain, bloating, urgency, and more. Not only...

• Gastroenteritis in Children: Signs of Dehydration

  Gastroenteritis is an intestinal infection that is caused by poorly prepared foods, contaminated water, etc. It can cause diarrhea, nausea, headache, and vomiting.What causes it?Gastro is caused by viruses. They include:• Rotavirus• AdenovirusHow is the gastroenteritis virus passed?Children can...

• Pancreatic Cancer: Where is the Pancreas Located in the Body?

  Pancreatic Cancer: Where is the Pancreas Located in the Body?Pancreatic cancer is likely to develop when the cells present in the pancreas multiply uncontrollably forming a cell mass. Do you want to know what is Pancreas? Do you want to know its functions? Do you want to know how it helps your body?...

• Accutane and Crohn’s: What You Need to Know

  According to the Crohn’s and Colitis Foundation of America, Crohn’s disease affects over 780,000 individuals living in the United States. Widely known as a common type of inflammatory bowel disease (IBD), Crohn’s causes chronic inflammation throughout the gastrointestinal tract. ...